Safety and Immunogenicity of the rVSV∆G-ZEBOV-GP Ebola Virus Vaccine Candidate in Healthy Adults: A Phase 1b Randomised, Multicentre, Double-Blind, Placebo-Controlled, Dose-Response Study

The Lancet Infectious Diseases - United Kingdom
doi 10.1016/s1473-3099(17)30313-4
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Safety and Immunogenicity of a Recombinant Adenovirus Type-5 Vector-Based Ebola Vaccine in Healthy Adults in Sierra Leone: A Single-Centre, Randomised, Double-Blind, Placebo-Controlled, Phase 2 Trial

The Lancet
Medicine
2017English

One-Year Safety of the Rvsv∆g-Zebov-Gp Vaccine in Adolescents and Children in Lambarene, Gabon

BMJ Global Health
Health PolicyPublic HealthOccupational HealthEnvironmental
2017English

A Phase 2/3 Double Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Immunogenicity of a Seasonal Trivalent Inactivated Split-Virion Influenza Vaccine (IVACFLU-S) in Healthy Adults in Vietnam

Human Vaccines and Immunotherapeutics
MedicineAllergyImmunologyPharmacology
2019English

Immunity Duration of a Recombinant Adenovirus Type-5 Vector-Based Ebola Vaccine and a Homologous Prime-Boost Immunisation in Healthy Adults in China: Final Report of a Randomised, Double-Blind, Placebo-Controlled, Phase 1 Trial

The Lancet Global Health
Medicine
2017English

Safety and Immunogenicity of a Parenteral P2-Vp8-P[8] Subunit Rotavirus Vaccine in Toddlers and Infants in South Africa: A Randomised, Double-Blind, Placebo-Controlled Trial

The Lancet Infectious Diseases
Infectious Diseases
2017English

Diclofenac Patch for Topical Treatment of Acute Impact Injuries: A Randomised, Double Blind, Placebo Controlled, Multicentre Study

British Journal of Sports Medicine
Sports MedicinePhysical TherapySports ScienceSports TherapyOrthopedicsMedicineRehabilitation
2004English

Randomised, Double-Blind, Placebo-Controlled Trial of EPs 7630 in Adults With COPD

Respiratory Medicine
PulmonaryRespiratory Medicine
2013English

Efficacy and Safety of Analgesic Treatment for Depression in People With Advanced Dementia: Randomised, Multicentre, Double-Blind, Placebo-Controlled Trial (DEP.PAIN.DEM)

Drugs and Aging
GerontologyGeriatricsPharmacology
2018English

A 6-Week, Multicentre, Randomised, Double-Blind, Double-Dummy, Active-Controlled, Clinical Safety Study of Lumiracoxib and Rofecoxib in Osteoarthritis Patients

BMC Musculoskeletal Disorders
RheumatologyOrthopedicsSports Medicine
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy